Evidence map›Paper›PMID 25533446›Full record

ArticleMicrobiology (Reading, England)2015

LPS modification promotes maintenance of Yersinia pestis in fleas.

Kari L Aoyagi, Benjamin D Brooks, Scott W Bearden, John A Montenieri, Kenneth L Gage, Mark A Fisher

Open access · greenAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Polymyxins retainAntimicrobial agents and chemotherapy · 2024
    Article
  3. Mutation ofMicrobiology (Reading, England) · 2024
    Article
  4. Article
  5. Article
  6. Lipopolysaccharide of theBiomolecules · 2021
    Review
  7. ACS infectious diseases · 2021
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Co-infection Assay to Determine Yersinia pestis Competitive Fitness in Fleas.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kari L AoyagiUniversity of Utah Department of Pathology, 2100 JMRB, 15 North Medical Drive East, Salt Lake City, UT 84132, USA.
Benjamin D BrooksUniversity of Utah Department of Pathology, 2100 JMRB, 15 North Medical Drive East, Salt Lake City, UT 84132, USA.
Scott W BeardenDivision of Vector-Borne Diseases, Bacterial Diseases Branch, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA.
John A MontenieriDivision of Vector-Borne Diseases, Bacterial Diseases Branch, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA.
Kenneth L GageDivision of Vector-Borne Diseases, Bacterial Diseases Branch, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, USA.
Mark A FisherUniversity of Utah Department of Pathology, 2100 JMRB, 15 North Medical Drive East, Salt Lake City, UT 84132, USA ARUP Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA mark.fisher@path.utah.edu.
Centers for Disease Control and Prevention · USUniversity of Utah · USARUP Laboratories (United States) · US

Funding

Vascular stabilization as a broad theraprutic platform for biodefenseU54AI065357 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI SCHWEIZER, HERBERT P. · 2005 to 2013
$77.5M
NIAID NIH HHS U54 AI-065357NIAID NIH HHS U54 AI065357
6 · The paper itself

Abstract

Yersinia pestis, the causative agent of plague, can be transmitted by fleas by two different mechanisms: by early-phase transmission (EPT), which occurs shortly after flea infection, or by blocked fleas following long-term infection. Efficient flea-borne transmission is predicated upon the ability of Y. pestis to be maintained within the flea. Signature-tagged mutagenesis (STM) was used to identify genes required for Y. pestis maintenance in a genuine plague vector, Xenopsylla cheopis. The STM screen identified seven mutants that displayed markedly reduced fitness in fleas after 4 days, the time during which EPT occurs. Two of the mutants contained insertions in genes encoding glucose 1-phosphate uridylyltransferase (galU) and UDP-4-amino-4-deoxy-l-arabinose-oxoglutarate aminotransferase (arnB), which are involved in the modification of lipid A with 4-amino-4-deoxy-l-arabinose (Ara4N) and resistance to cationic antimicrobial peptides (CAMPs). These Y. pestis mutants were more susceptible to the CAMPs cecropin A and polymyxin B, and produced lipid A lacking Ara4N modifications. Surprisingly, an in-frame deletion of arnB retained modest levels of CAMP resistance and Ara4N modification, indicating the presence of compensatory factors. It was determined that WecE, an aminotransferase involved in biosynthesis of enterobacterial common antigen, plays a novel role in Y. pestis Ara4N modification by partially offsetting the loss of arnB. These results indicated that mechanisms of Ara4N modification of lipid A are more complex than previously thought, and these modifications, as well as several factors yet to be elucidated, play an important role in early survival and transmission of Y. pestis in the flea vector.

Indexed as

AnimalsBacterial ProteinsHumansInsect VectorsLipid AMicrobial ViabilityPlagueRatsRats, Sprague-DawleySiphonapteraYersinia pestisBacterial ProteinsLipid A

Identifiers

PMID25533446
PMCPMC4339655
OpenAlexW2127547294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.